139 related articles for article (PubMed ID: 9535416)
41. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
42. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
McDonald JE; Padmanabhan N; Petrie MC; Hillier C; Connell JM; McMurray JJ
Circulation; 2001 Oct; 104(15):1805-8. PubMed ID: 11591618
[TBL] [Abstract][Full Text] [Related]
43. Polymorphisms of the angiotensin converting enzyme gene in Iranian Azeri Turkish women with unexplained recurrent pregnancy loss.
Bagheri M; Abdi Rad I; Omrani MD; Nanbaksh F
Hum Fertil (Camb); 2010; 13(2):79-82. PubMed ID: 20722577
[TBL] [Abstract][Full Text] [Related]
44. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis.
Nishio K; Kashiki S; Tachibana H; Kobayashi Y
World J Cardiol; 2011 Oct; 3(10):329-36. PubMed ID: 22053221
[TBL] [Abstract][Full Text] [Related]
46. Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.
Nikpoor B; Duan QL; Rouleau GA
Expert Opin Pharmacother; 2005 Sep; 6(11):1851-6. PubMed ID: 16144506
[TBL] [Abstract][Full Text] [Related]
47. What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review.
Scharplatz M; Puhan MA; Steurer J; Bachmann LM
BMC Med Genet; 2004 Sep; 5():23. PubMed ID: 15361261
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin converting enzyme inhibitor induced cough in Nigerians.
Adigun AQ; Ajayi AA
West Afr J Med; 2001; 20(1):46-7. PubMed ID: 11505887
[TBL] [Abstract][Full Text] [Related]
49. The cough reflex is upregulated by lisinopril microinjected into the caudal nucleus tractus solitarii of the rabbit.
Cinelli E; Bongianni F; Pantaleo T; Mutolo D
Respir Physiol Neurobiol; 2015 Dec; 219():9-17. PubMed ID: 26234277
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
[TBL] [Abstract][Full Text] [Related]
51. Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.
Shiota N; Fukamizu A; Okunishi H; Takai S; Murakami K; Miyazaki M
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):417-24. PubMed ID: 9657983
[TBL] [Abstract][Full Text] [Related]
52. Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.
Lee JK; Wu CK; Tsai CT; Lin LY; Lin JW; Chien KL; Hwang JJ; Lin CL; Tseng CD; Chiang FT
Pharmacogenet Genomics; 2013 Apr; 23(4):181-9. PubMed ID: 23407050
[TBL] [Abstract][Full Text] [Related]
53. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
[TBL] [Abstract][Full Text] [Related]
54. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
55. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura.
Kowa H; Fusayasu E; Ijiri T; Ishizaki K; Yasui K; Nakaso K; Kusumi M; Takeshima T; Nakashima K
Neurosci Lett; 2005 Feb; 374(2):129-31. PubMed ID: 15644278
[TBL] [Abstract][Full Text] [Related]
56. Cough due to ACE inhibitors: a case-control study using automated general practice data.
Visser LE; Vlug AE; van der Lei J; Stricker BH
Eur J Clin Pharmacol; 1996; 49(6):439-44. PubMed ID: 8706767
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation.
Su X; Wei CC; Machida N; Bishop SP; Hankes GH; Dillon RA; Oparil S; Dell Italia LJ
J Mol Cell Cardiol; 1999 May; 31(5):1033-45. PubMed ID: 10339353
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.
Niu T; Chen X; Xu X
Drugs; 2002; 62(7):977-93. PubMed ID: 11985486
[TBL] [Abstract][Full Text] [Related]
59. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
Rugale C; du Cailar G; Ribstein J; Mimran A
Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
[TBL] [Abstract][Full Text] [Related]
60. Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia.
Ouyang WC; Wang YC; Hong CJ; Cheng CY; Tsai SJ
Neuropsychobiology; 2001; 44(1):31-5. PubMed ID: 11408790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
